A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML

Blood Cancer J. 2016 Apr 8;6(4):e413. doi: 10.1038/bcj.2016.18.

Authors

K Krysiak¹, M J Christopher², Z L Skidmore¹, R T Demeter¹, V Magrini¹, J Kunisaki¹, M O'Laughlin¹, E J Duncavage³, C A Miller^{1

2}, B A Ozenberger^{1

2}, M Griffith^{1

4

5}, L D Wartman^{1

2

5}, O L Griffith^{1

2

4

5}

Affiliations

¹ McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA.
² Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
³ Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
⁴ Department of Genetics, Washington University School of Medicine, St Louis, MO, USA.
⁵ Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA.

No abstract available

Publication types

Case Reports
Letter
Research Support, N.I.H., Extramural

MeSH terms

Biopsy
Blast Crisis / genetics*
Disease Progression
Exome
Genomics*
High-Throughput Nucleotide Sequencing
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
Leukemia, Myeloid, Acute / diagnosis
Leukemia, Myeloid, Acute / genetics*
Leukemia, Myeloid, Acute / pathology*
Philadelphia Chromosome*

Grants and funding